Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.65 |
| ▸ | PPARD | Q03181 | 8/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL448405 | 0.87 | CDK1 (0.74) | PPARGPPARDADORA3ADORA2AADORA1 | |
| SCHEMBL6817859 | 0.87 | CDK1 (0.74) | ADORA2AADORA1 | |
| SCHEMBL5196107 | 0.82 | CDK1 (0.64) | PPARGPPARDADORA3ADORA2AADORA1 | |
| SCHEMBL5193584 | 0.82 | CDK1 (0.61) | PPARGPPARDADORA3ADORA2AADORA1 | |
| SCHEMBL28771447 | 0.82 | PPARD (0.64) | PPARGPPARDADORA3ADORA2AADORA1 | |
| SCHEMBL6152650 | 0.82 | CTSL (0.69) | ADORA2AADORA1 | |
| SCHEMBL6820864 | 0.82 | CDK1 (0.76) | PPARGPPARDADORA3ADORA2AADORA1 | |
| SCHEMBL17628618 | 0.82 | CDK1 (0.57) | ADORA3ADORA2AADORA1 | |
| SCHEMBL17628578 | 0.81 | CDK1 (0.65) | ADORA2AADORA1 | |
| SCHEMBL6945059 | 0.80 | CCNE2 (0.57) | PPARDADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1056745-B1 | 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | AVENTIS PHARMA INC (US) | 2004-06-16 | — | — | EP | disclosed |
| US-6413974-B1 | INHIBITORS OF CYCLIN DEPENDENT KINASES, PARTICULARLY CDK-2; PREVENTING APOPTOSIS IN NEURONAL CELLS; ANTINEOPLASTIC AGENTS; NEURONAL INJURY AND DEGENERATION; CEREBROVASCULAR DISEASE | AVENTIS PHARMACEUTICALS INC. | 2002-07-02 | — | — | US | disclosed |
| EP-1056745-A2 | 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | Aventis Pharmaceuticals Inc. (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999043676-A2 | 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | AVENTIS PHARMACEUTICALS INC. (US) | 1999-09-02 | — | — | WO | disclosed |